Cortical Thickness Changes in Chronic Ketamine Users
- PMID: 33841212
- PMCID: PMC8026883
- DOI: 10.3389/fpsyt.2021.645471
Cortical Thickness Changes in Chronic Ketamine Users
Abstract
Background: Previous studies have examined the effects of long-term ketamine use on gray matter volume. But it is unclear whether chronic ketamine use alters cortical thickness and whether cortical thickness changes in chronic ketamine users are associated with cognitive deficits observed in chronic ketamine users. Methods: Here, 28 chronic ketamine users and 30 healthy controls (HCs) were recruited. Cortical morphometry based on Computational Anatomy Toolbox (CAT12) was used to measure cortical thickness. Cognitive performance was measured by MATRICS Consensus Cognitive Battery (MCCB). Two-sample t-test was used to assess differences in cortical thickness and cognitive performance between the two groups. Partial correlation analysis was used for assessing correlations between cortical thickness changes and clinical characteristics, cognitive performance in chronic ketamine users. Results: Chronic ketamine users exhibited significantly reduced cortical thickness in frontal, parietal, temporal, and occipital lobes compared to HC [false discovery rate (FDR) corrected at p < 0.05]. In chronic ketamine users, the average quantity (g) of ketamine use/day was negatively correlated with cortical thickness in the left superior frontal gyrus (SFG), right caudal middle frontal gyrus (MFG), and right paracentral lobule. The frequency of ketamine use (days per week) was negatively correlated with cortical thickness in the left isthmus cingulate cortex. Duration of ketamine use (month) was negatively correlated with cortical thickness in the left precentral gyrus. The chronic ketamine users showed significantly poorer cognitive performance on the working memory (P = 0.009), visual learning (P = 0.009), speed of processing (P < 0.000), and Matrics composite (P = 0.01). There was no correlation between scores of domains of MCCB and reduced cortical thickness. Conclusion: The present study observed reduced cortical thickness in multiple brain areas, especially in the prefrontal cortex (PFC) in chronic ketamine users. Dose, frequency, and duration of ketamine use was negatively correlated with cortical thickness of some brain areas. Our results suggest that chronic ketamine use may lead to a decrease of cortical thickness. But the present study did not observe any correlation between reduced cortical thickness and decreased cognitive performance in chronic ketamine users.
Keywords: cortical thickness; frontal lobes; gray matter; ketamine; ketamine dependent; surface-based morphometry.
Copyright © 2021 Zhong, Wu, Wu, He, Zhang, Huang, Cao and Fan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Cortical Surface Thickness in the Middle-Aged Brain with White Matter Hyperintense Lesions.Front Aging Neurosci. 2017 Jul 17;9:225. doi: 10.3389/fnagi.2017.00225. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28769784 Free PMC article.
-
Abnormal resting-state functional connectivity of the right anterior cingulate cortex in chronic ketamine users and its correlation with cognitive impairments.Asian J Psychiatr. 2024 Dec;102:104199. doi: 10.1016/j.ajp.2024.104199. Epub 2024 Sep 14. Asian J Psychiatr. 2024. PMID: 39298913
-
Abnormal fractional Amplitude of Low-Frequency Fluctuation in chronic ketamine users.Psychiatry Res Neuroimaging. 2022 Oct;326:111536. doi: 10.1016/j.pscychresns.2022.111536. Epub 2022 Aug 28. Psychiatry Res Neuroimaging. 2022. PMID: 36067548
-
Brain Changes Associated With Long-Term Ketamine Abuse, A Systematic Review.Front Neuroanat. 2022 Mar 18;16:795231. doi: 10.3389/fnana.2022.795231. eCollection 2022. Front Neuroanat. 2022. PMID: 35370568 Free PMC article.
-
A systematic review of the impact of type 2 diabetes on brain cortical thickness.Front Dement. 2024 Jun 13;3:1418037. doi: 10.3389/frdem.2024.1418037. eCollection 2024. Front Dement. 2024. PMID: 39081608 Free PMC article.
Cited by
-
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.Curr Pain Headache Rep. 2021 Dec 11;25(12):77. doi: 10.1007/s11916-021-00992-x. Curr Pain Headache Rep. 2021. PMID: 34894295 Free PMC article. Review.
-
Grey matter volume and its association with cognitive impairment and peripheral cytokines in excited individuals with schizophrenia.Brain Imaging Behav. 2022 Dec;16(6):2618-2626. doi: 10.1007/s11682-022-00717-7. Epub 2022 Nov 7. Brain Imaging Behav. 2022. PMID: 36342634
-
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review.Pharmacotherapy. 2022 Jul;42(7):567-579. doi: 10.1002/phar.2707. Epub 2022 Jun 26. Pharmacotherapy. 2022. PMID: 35665948 Free PMC article. Review.
-
Widespread reductions in cortical thickness following ketamine abuse.J Psychiatry Neurosci. 2024 May 30;49(3):E182-E191. doi: 10.1503/jpn.230111. Print 2024 May-Jun. J Psychiatry Neurosci. 2024. PMID: 38816028 Free PMC article.
-
Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.Intell Med. 2022 May;2(2):61-68. doi: 10.1016/j.imed.2022.03.001. Epub 2022 Mar 7. Intell Med. 2022. PMID: 35783539 Free PMC article.
References
-
- Ng SH, Tse ML, Ng HW, Lau FL. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med. J. (2010) 16:6–11. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous